HomeCompareSBNY vs PFE

SBNY vs PFE: Dividend Comparison 2026

SBNY yields 307.69% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBNY wins by $1796.20M in total portfolio value
10 years
SBNY
SBNY
● Live price
307.69%
Share price
$0.65
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1796.25M
Annual income
$1,095,723,615.05
Full SBNY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — SBNY vs PFE

📍 SBNY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBNYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBNY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBNY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBNY
Annual income on $10K today (after 15% tax)
$26,153.85/yr
After 10yr DRIP, annual income (after tax)
$931,365,072.79/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, SBNY beats the other by $931,342,752.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBNY + PFE for your $10,000?

SBNY: 50%PFE: 50%
100% PFE50/50100% SBNY
Portfolio after 10yr
$898.15M
Annual income
$547,874,936.89/yr
Blended yield
61.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBNY right now

SBNY
Analyst Ratings
21
Buy
6
Hold
Consensus: Buy
Price Target
$273.70
+42007.7% upside vs current
Range: $132.00 — $450.00
Altman Z
-0.6
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBNY buys
0
PFE buys
0
No recent congressional trades found for SBNY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBNYPFE
Forward yield307.69%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$1796.25M$49.6K
Annual income after 10y$1,095,723,615.05$26,258.71
Total dividends collected$1726.57M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold
Analyst price target$273.70$27.50

Year-by-year: SBNY vs PFE ($10,000, DRIP)

YearSBNY PortfolioSBNY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$41,469$30,769.23$9,153$693.39+$32.3KSBNY
2$163,622$119,250.12$8,593$849.25+$155.0KSBNY
3$614,811$439,735.28$8,336$1,066.78+$606.5KSBNY
4$2,202,060$1,544,212.14$8,437$1,384.80+$2.19MSBNY
5$7,525,253$5,169,049.22$9,013$1,875.40+$7.52MSBNY
6$24,560,949$16,508,928.16$10,306$2,680.72+$24.55MSBNY
7$76,637,131$50,356,915.57$12,820$4,101.38+$76.62MSBNY
8$228,850,204$146,848,473.02$17,673$6,826.70+$228.83MSBNY
9$654,694,032$409,824,313.91$27,543$12,591.86+$654.67MSBNY
10$1,796,246,229$1,095,723,615.05$49,560$26,258.71+$1796.20MSBNY

SBNY vs PFE: Complete Analysis 2026

SBNYStock

Signature Bank provides commercial banking products and services. It accepts various deposit products, including checking accounts, money market accounts, escrow deposit accounts, cash concentration accounts, certificates of deposit, and other cash management products. The company provides various lending products comprising commercial and industrial loans, real estate loans, and letters of credit. In addition, it offers asset management and investment products; and retirement products, such as individual retirement accounts and administrative services for retirement vehicles. Further, the company provides wealth management services to its high net worth personal clients; and purchases, sells, and assembles small business administration loans and pools. Additionally, it offers individual and group insurance products, including health, life, disability, and long-term care insurance products for business and private clients. As of December 31, 2021, the company operated 37 private client offices located in the metropolitan New York area, Connecticut, California, and North Carolina. Signature Bank was incorporated in 2000 and is headquartered in New York, New York.

Full SBNY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SBNY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBNY vs SCHDSBNY vs JEPISBNY vs OSBNY vs KOSBNY vs MAINSBNY vs JNJSBNY vs MRKSBNY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.